A coinsurance rate decrease can result in increased adherence to oral antihyperglycemic agents and improved clinical outcomes and cost savings for the healthcare system.
Kostas Athanasakis, MSc
Advertisement
Articles by Kostas Athanasakis, MSc
Advertisement
Latest Updated Articles
- Abolishing Coinsurance for Oral Antihyperglycemic Agents: Effects on Social Insurance Budgets
Published: March 7th 2011 | Updated:
Advertisement
Advertisement
